Drugs / DHA Omega-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01883817 | Sep 2013 → Mar 2017 | attention deficit-hyperactivity disorder | University of Cincinnati | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DHA Omega-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01883817 ↗ |